Leading Element Driving Change in the GMP Cell Therapy Consumables Market in 2025: Rise In Drug Discovery Drives Growth Of Gmp Cell Therapy Consumables Market Driver

How Are the key drivers contributing to the expansion of the gmp cell therapy consumables market?
The GMP cell therapy consumables market is projected to grow due to the increased activity in drug discovery. Drug discovery entails the process of finding new potential medicinal entities, a process that integrates computational, experimental, translational, and clinical models. Thanks to advancements in molecular biology, genetics, bioinformatics, and high-throughput screening techniques, drug discovery has experienced a radical transformation. These advancements equip scientists with the understanding of disease mechanisms in greater depth, allowing them to pinpoint potential drug targets and sift through huge libraries of compounds to efficiently find drug candidates. This boost in drug discovery activities is fueling the growth of the GMP cell therapy consumables market. To give an example, in January 2023, the US's Food and Drug Administration, a federal agency within the Department of Health and Human Services, reported that the FDA's Centre for Drug Evaluation and Research (CDER) had approved 37 new drugs and therapeutic biological products for various indications in 2022. As a result of this increase in drug discovery, the GMP cell therapy consumables market is experiencing significant growth.

Get Your GMP Cell Therapy Consumables Market Report Here:
https://www.thebusinessresearchcompany.com/report/gmp-cell-therapy-consumables-global-market-report

What growth opportunities are expected to drive the gmp cell therapy consumables market's CAGR through 2034?
In recent years, the market size for GMP cell therapy consumables has experienced significant expansion. This trend is anticipated to continue with the market's projected growth from $17.85 billion in 2024 to $22.87 billion in 2025, reflecting a compound annual growth rate (CAGR) of 28.1%. Factors contributing to this past growth include heightened investment in regenerative medicine, the progression of cell therapy research, a surge in clinical trials and their approvals, an increased incidence of chronic illnesses, and an elevated awareness of personalized medicine.

In the coming years, the market size for GMP cell therapy consumables is anticipated to witness explosive growth, reaching $59 billion by the year 2029 with a compound annual growth rate (CAGR) of 26.7%. The expansion of cell therapy applications, increased cell therapy trials globally, regulatory support for cell therapies, the emergence of innovative cell therapy platforms, and global manufacturing of cell therapy contribute to this growth during the forecast period. Key trends projected for the forecast period include investment in manufacturing infrastructure, technological advancements in cell processing, collaborations and partnerships, as well as digitalization and data integration, and strategic alliances alongside mergers.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12014&type=smp

What are the emerging trends shaping the future of the gmp cell therapy consumables market?
Leading firms in the GMP cell therapy consumables market are focusing on creating GMP-compliant CD34+ hematopoietic stem cells (HSCs) to bolster advanced therapies. The term GMP-compliant CD34+ hematopoietic stem cells (HSCs) denotes a unique stem cell variant which exhibits the CD34 marker on its surface, and is manufactured under Good Manufacturing Practice (GMP) conditions. For example, OrganaBio, an American pharmaceutical enterprise, in April 2024, initiated HematoPAC-HSC-CB-GMP, a readily available source of GMP-compliant CD34+ hematopoietic stem cells (HSCs) extracted from fresh human cord blood. Taking advantage of their vast expertise in cell isolation and GMP production, OrganaBio generates high amounts of highly viable CD34+ HSCs within a day of collection. The objective of this introduction is to facilitate the creation of pioneering therapies, such as those for blood cancer and genetic anomalies.

Which growth-oriented segments of the gmp cell therapy consumables market are leading the industry's development?
The GMP cell therapy consumables market covered in this report is segmented -

1) By Product: Kits, Reagents Or Molecular Biology reagents, Growth Factors Or Cytokines And Interleukins, Other Products
2) By Cell Therapy: NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, Other cell therapies
3) By Process: Cell Collection And Characterization Or Sorting And Separation, Cell Culture And Expansion Or Preparation, Cryopreservation, Cell Processing And Formulation, Cell Isolation And Activation, Cell Distribution Or Handling, Process Monitoring And Control Or Readministration Or Quality Assurance, Other Processes
4) By End-Use: Clinical, Commercial, Research

Subsegments:
1) By Kits: Cell Culture Kits, Cell Isolation Kits, Transfection Kits
2) By Reagents Or Molecular Biology Reagents: Buffers And Solutions, Enzymes, Staining Reagents
3) By Growth Factors Or Cytokines And Interleukins: Hematopoietic Growth Factors, Antibody Cytokines, Immunomodulatory Cytokines
3) By Other Products: Cell Culture Vessels, Bioreactors, Media And Supplements

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12014

What regions are leading the charge in the gmp cell therapy consumables market?
North America was the largest region in the GMP cell therapy consumables market in 2024. Asia-pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the GMP cell therapy consumables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the gmp cell therapy consumables market?
Major companies operating in the GMP cell therapy consumables market include Thermo Fisher Scientific Inc., Fresenius Kabi AG, Danaher Corporation, Merck KGaA, Asahi Kasei Corporation, GE HealthCare Technologies Inc., Corning Incorporated, Avantor Inc., Lonza Group AG, Terumo Corporation, Catalent Inc., Sartorius AG, Bio-Techne Corp, Repligen Corporation, Miltenyi Biotec BV & Co KG, Genscript Biotech Corporation, Rentschler Biopharma SE, FUJIFILM Irvine Scientific Inc., BioLegend Inc., STEMCELL Technologies Inc., BioLife Solutions Inc., Abzena Ltd., Sino Biological Inc., ProBioGen AG, MaxCyte Inc., PromoCell GmbH, PeproTech Inc., Cellares Corp., Wilson Wolf Corporation, Cellexus Ltd.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12014&type=smp

What Is Covered In The GMP Cell Therapy Consumables Global Market Report?

• Market Size Forecast: Examine the gmp cell therapy consumables market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the gmp cell therapy consumables market for a structured understanding.
• Key Players Overview: Analyze major players in the gmp cell therapy consumables market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the gmp cell therapy consumables market.
• Segment Contributions: Evaluate how different segments drive overall growth in the gmp cell therapy consumables market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the gmp cell therapy consumables market.
• Industry Challenges: Identify potential risks and obstacles affecting the gmp cell therapy consumables market.
• Competitive Landscape: Review strategic developments in the gmp cell therapy consumables market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.